Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?
Aletaha, Daniel, Smolen, Josef S.Volume:
45
Language:
english
Journal:
Rheumatic Disease Clinics of North America
DOI:
10.1016/j.rdc.2019.04.002
Date:
August, 2019
File:
PDF, 413 KB
english, 2019